{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T08:11:10Z","timestamp":1795075870006,"version":"4.10.2"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T00:00:00Z","timestamp":1533254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T00:00:00Z","timestamp":1533254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P01AI112524"],"award-info":[{"award-number":["P01AI112524"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI112381"],"award-info":[{"award-number":["R01AI112381"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI109464"],"award-info":[{"award-number":["R21AI109464"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI127744"],"award-info":[{"award-number":["AI127744"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Current efforts to develop Zika virus (ZIKV) subunit vaccines have been focused on pre-membrane (prM) and envelope (E) proteins, but the role of NS1 in ZIKV-specific immune response and protection is poorly understood. Here, we develop an attenuated recombinant vesicular stomatitis virus (rVSV)-based vaccine expressing ZIKV prM-E-NS1 as a polyprotein. This vectored vaccine candidate is attenuated in mice, where a single immunization induces ZIKV-specific antibody and T cell immune responses that provide protection against ZIKV challenge. Co-expression of prM, E, and NS1 induces significantly higher levels of Th2 and Th17 cytokine responses than prM-E. In addition, NS1 alone is capable of conferring partial protection against ZIKV infection in mice even though it does not induce neutralizing antibodies. These results demonstrate that attenuated rVSV co-expressing prM, E, and NS1 is a promising vaccine candidate for protection against ZIKV infection and highlights an important role for NS1 in ZIKV-specific cellular immune responses.<\/jats:p>","DOI":"10.1038\/s41467-018-05276-4","type":"journal-article","created":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T14:20:19Z","timestamp":1532960419000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein"],"prefix":"10.1038","volume":"9","author":[{"given":"Anzhong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyou","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mijia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanmei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zayed","family":"Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3953-3782","authenticated-orcid":false,"given":"Chao","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaoge","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueya","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirajkumar","family":"Makadiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer J.","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Yong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Peeples","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prosper N.","family":"Boyaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianrong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,3]]},"reference":[{"key":"5276_CR1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/0035-9203(52)90042-4","volume":"46","author":"GW Dick","year":"1952","unstructured":"Dick, G. W., Kitchen, S. F. & Haddow, A. J. Zika virus. I. Isolations and serological specificity. Trans. R. Soc. Trop. Med. Hyg. 46, 509\u2013520 (1952).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"5276_CR2","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/0035-9203(52)90043-6","volume":"46","author":"GW Dick","year":"1952","unstructured":"Dick, G. W. Zika virus. II. Pathogenicity and physical properties. Trans. R. Soc. Trop. Med. Hyg. 46, 521\u2013534 (1952).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"5276_CR3","doi-asserted-by":"publisher","first-page":"304ra141","DOI":"10.1126\/scitranslmed.aaa3787","volume":"7","author":"PR Beatty","year":"2015","unstructured":"Beatty, P. R. et al. Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination. Sci. Transl. Med. 7, 304ra141 (2015).","journal-title":"Sci. Transl. Med."},{"key":"5276_CR4","doi-asserted-by":"publisher","first-page":"e1477","DOI":"10.1371\/journal.pntd.0001477","volume":"6","author":"AD Haddow","year":"2012","unstructured":"Haddow, A. D. et al. Genetic characterization of Zika virus strains: geographic expansion of the Asian lineage. PLoS Negl. Trop. Dis. 6, e1477 (2012).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"5276_CR5","doi-asserted-by":"publisher","first-page":"4864","DOI":"10.1128\/JVI.00252-16","volume":"90","author":"HM Lazear","year":"2016","unstructured":"Lazear, H. M. & Diamond, M. S. Zika virus: new clinical syndromes and its emergence in the Western Hemisphere. J. Virol. 90, 4864\u20134875 (2016).","journal-title":"J. Virol."},{"key":"5276_CR6","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1056\/NEJMoa1602412","volume":"375","author":"P Brasil","year":"2016","unstructured":"Brasil, P. et al. Zika virus infection in pregnant women in Rio de Janeiro. N. Engl. J. Med. 375, 2321\u20132334 (2016).","journal-title":"N. Engl. J. Med."},{"key":"5276_CR7","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","volume":"387","author":"VM Cao-Lormeau","year":"2016","unstructured":"Cao-Lormeau, V. M. et al. Guillain-Barre Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 387, 1531\u20131539 (2016).","journal-title":"Lancet"},{"key":"5276_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3201\/eid2301.161394","volume":"23","author":"KO Murray","year":"2017","unstructured":"Murray, K. O. et al. Prolonged detection of Zika virus in vaginal secretions and whole blood. Emerg. Infect. Dis. 23, 99\u2013101 (2017).","journal-title":"Emerg. Infect. Dis."},{"key":"5276_CR9","doi-asserted-by":"publisher","first-page":"716","DOI":"10.15585\/mmwr.mm6528e2","volume":"65","author":"A Davidson","year":"2016","unstructured":"Davidson, A., Slavinski, S., Komoto, K., Rakeman, J. & Weiss, D. Suspected female-to-male sexual transmission of Zika virus\u2014New York City, 2016. Mmwr. Morb. Mortal. Wkly Rep. 65, 716\u2013717 (2016).","journal-title":"Mmwr. Morb. Mortal. Wkly Rep."},{"key":"5276_CR10","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1056\/NEJMc1604449","volume":"374","author":"E D\u2019Ortenzio","year":"2016","unstructured":"D\u2019Ortenzio, E. et al. Evidence of sexual transmission of Zika virus. N. Engl. J. Med. 374, 2195\u20132198 (2016).","journal-title":"N. Engl. J. Med."},{"key":"5276_CR11","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1146\/annurev.mi.44.100190.003245","volume":"44","author":"TJ Chambers","year":"1990","unstructured":"Chambers, T. J., Hahn, C. S., Galler, R. & Rice, C. M. Flavivirus genome organization, expression, and replication. Annu. Rev. Microbiol. 44, 649\u2013688 (1990).","journal-title":"Annu. Rev. Microbiol."},{"key":"5276_CR12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nature17994","volume":"533","author":"VA Kostyuchenko","year":"2016","unstructured":"Kostyuchenko, V. A. et al. Structure of the thermally stable Zika virus. Nature 533, 425\u2013428 (2016).","journal-title":"Nature"},{"key":"5276_CR13","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1126\/science.aaf5316","volume":"352","author":"D Sirohi","year":"2016","unstructured":"Sirohi, D. et al. The 3.8 A resolution cryo-EM structure of Zika virus. Science 352, 467\u2013470 (2016).","journal-title":"Science"},{"key":"5276_CR14","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.chom.2016.04.013","volume":"19","author":"L Dai","year":"2016","unstructured":"Dai, L. et al. Structures of the Zika virus envelope protein and its complex with a flavivirus broadly protective antibody. Cell Host Microbe 19, 696\u2013704 (2016).","journal-title":"Cell Host Microbe"},{"key":"5276_CR15","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1128\/JVI.73.7.5605-5612.1999","volume":"73","author":"SL Allison","year":"1999","unstructured":"Allison, S. L., Stiasny, K., Stadler, K., Mandl, C. W. & Heinz, F. X. Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E. J. Virol. 73, 5605\u20135612 (1999).","journal-title":"J. Virol."},{"key":"5276_CR16","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1128\/jvi.69.9.5816-5820.1995","volume":"69","author":"SL Allison","year":"1995","unstructured":"Allison, S. L., Stadler, K., Mandl, C. W., Kunz, C. & Heinz, F. X. Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form. J. Virol. 69, 5816\u20135820 (1995).","journal-title":"J. Virol."},{"key":"5276_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1126\/science.aai9137","volume":"354","author":"KA Dowd","year":"2016","unstructured":"Dowd, K. A. et al. Rapid development of a DNA vaccine for Zika virus. Science 354, 237\u2013240 (2016).","journal-title":"Science"},{"key":"5276_CR18","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.cell.2017.02.017","volume":"168","author":"JM Richner","year":"2017","unstructured":"Richner, J. M. et al. Modified mRNA vaccines protect against Zika virus infection. Cell 168, 1114\u20131125 (2017). e1110.","journal-title":"Cell"},{"key":"5276_CR19","doi-asserted-by":"publisher","first-page":"e0005608","DOI":"10.1371\/journal.pntd.0005608","volume":"11","author":"H Boigard","year":"2017","unstructured":"Boigard, H. et al. Zika virus-like particle (VLP) based vaccine. PLoS Negl. Trop. Dis. 11, e0005608 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"5276_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41594-017-0010-8","volume":"25","author":"SS Hasan","year":"2018","unstructured":"Hasan, S. S., Sevvana, M., Kuhn, R. J. & Rossmann, M. G. Structural biology of Zika virus and other flaviviruses. Nat. Struct. Mol. Biol. 25, 13\u201320 (2018).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"5276_CR21","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1016\/j.vaccine.2005.08.022","volume":"24","author":"SM Costa","year":"2006","unstructured":"Costa, S. M., Freire, M. S. & Alves, A. M. DNA vaccine against the non-structural 1 protein (NS1) of dengue 2 virus. Vaccine 24, 4562\u20134564 (2006).","journal-title":"Vaccine"},{"key":"5276_CR22","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1016\/S0264-410X(03)00310-4","volume":"21","author":"SF Wu","year":"2003","unstructured":"Wu, S. F. et al. Evaluation of protective efficacy and immune mechanisms of using a non-structural protein NS1 in DNA vaccine against dengue 2 virus in mice. Vaccine 21, 3919\u20133929 (2003).","journal-title":"Vaccine"},{"key":"5276_CR23","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1099\/0022-1317-77-6-1287","volume":"77","author":"RA Hall","year":"1996","unstructured":"Hall, R. A. et al. Protective immune responses to the E and NS1 proteins of Murray Valley encephalitis virus in hybrids of flavivirus-resistant mice. J. Gen. Virol. 77, 1287\u20131294 (1996).","journal-title":"J. Gen. Virol."},{"key":"5276_CR24","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.vaccine.2009.10.112","volume":"28","author":"MC Whiteman","year":"2010","unstructured":"Whiteman, M. C. et al. Development and characterization of non-glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virus. Vaccine 28, 1075\u20131083 (2010).","journal-title":"Vaccine"},{"key":"5276_CR25","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1128\/JVI.80.3.1340-1351.2006","volume":"80","author":"KM Chung","year":"2006","unstructured":"Chung, K. M. et al. Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms. J. Virol. 80, 1340\u20131351 (2006).","journal-title":"J. Virol."},{"key":"5276_CR26","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1073\/pnas.1322036111","volume":"111","author":"MA Edeling","year":"2014","unstructured":"Edeling, M. A., Diamond, M. S. & Fremont, D. H. Structural basis of Flavivirus NS1 assembly and antibody recognition. Proc. Natl Acad. Sci. USA 111, 4285\u20134290 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"5276_CR27","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1126\/science.aah6157","volume":"353","author":"P Abbink","year":"2016","unstructured":"Abbink, P. et al. Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys. Science 353, 1129\u20131132 (2016).","journal-title":"Science"},{"key":"5276_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-00193-w","volume":"7","author":"JS Chahal","year":"2017","unstructured":"Chahal, J. S. et al. An RNA nanoparticle vaccine against Zika virus elicits antibody and CD8+ T cell responses in a mouse model. Sci. Rep. 7, 252 (2017).","journal-title":"Sci. Rep."},{"key":"5276_CR29","first-page":"1755","volume":"316","author":"T Hampton","year":"2016","unstructured":"Hampton, T. DNA vaccine protects monkeys against Zika virus infection. JAMA 316, 1755 (2016).","journal-title":"JAMA"},{"key":"5276_CR30","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/nature18952","volume":"536","author":"RA Larocca","year":"2016","unstructured":"Larocca, R. A. et al. Vaccine protection against Zika virus from Brazil. Nature 536, 474\u2013478 (2016).","journal-title":"Nature"},{"key":"5276_CR31","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nm.4322","volume":"23","author":"C Shan","year":"2017","unstructured":"Shan, C. et al. A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models. Nat. Med. 23, 763\u2013767 (2017).","journal-title":"Nat. Med."},{"key":"5276_CR32","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.06.040","volume":"170","author":"JM Richner","year":"2017","unstructured":"Richner, J. M. et al. Vaccine mediated protection against Zika virus-induced congenital disease. Cell 170, 273\u2013283 (2017).","journal-title":"Cell"},{"key":"5276_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00737-8","volume":"8","author":"C Shan","year":"2017","unstructured":"Shan, C. et al. A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage. Nat. Commun. 8, 676 (2017).","journal-title":"Nat. Commun."},{"key":"5276_CR34","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nature21428","volume":"543","author":"N Pardi","year":"2017","unstructured":"Pardi, N. et al. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature 543, 248\u2013251 (2017).","journal-title":"Nature"},{"key":"5276_CR35","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1128\/JVI.73.5.3723-3732.1999","volume":"73","author":"A Roberts","year":"1999","unstructured":"Roberts, A., Buonocore, L., Price, R., Forman, J. & Rose, J. K. Attenuated vesicular stomatitis viruses as vaccine vectors. J. Virol. 73, 3723\u20133732 (1999).","journal-title":"J. Virol."},{"key":"5276_CR36","doi-asserted-by":"publisher","first-page":"10293","DOI":"10.1128\/JVI.00919-06","volume":"80","author":"A Bukreyev","year":"2006","unstructured":"Bukreyev, A., Skiadopoulos, M. H., Murphy, B. R. & Collins, P. L. Nonsegmented negative-strand viruses as vaccine vectors. J. Virol. 80, 10293\u201310306 (2006).","journal-title":"J. Virol."},{"key":"5276_CR37","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0092-8674(01)00482-2","volume":"106","author":"NF Rose","year":"2001","unstructured":"Rose, N. F. et al. An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants. Cell 106, 539\u2013549 (2001).","journal-title":"Cell"},{"key":"5276_CR38","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1126\/science.aab3920","volume":"349","author":"A Marzi","year":"2015","unstructured":"Marzi, A. et al. EBOLA Vaccine. VSV-EBOV rapidly protects macaques against infection with the 2014\/15 Ebola virus outbreak strain. Science 349, 739\u2013742 (2015).","journal-title":"Science"},{"key":"5276_CR39","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/S1473-3099(15)00154-1","volume":"15","author":"A Huttner","year":"2015","unstructured":"Huttner, A. et al. The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1\/2 trial. Lancet Infect. Dis. 15, 1156\u20131166 (2015).","journal-title":"Lancet Infect. Dis."},{"key":"5276_CR40","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","volume":"389","author":"AM Henao-Restrepo","year":"2017","unstructured":"Henao-Restrepo, A. M. et al. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!). Lancet 389, 505\u2013518 (2017).","journal-title":"Lancet"},{"key":"5276_CR41","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0140-6736(15)61117-5","volume":"386","author":"AM Henao-Restrepo","year":"2015","unstructured":"Henao-Restrepo, A. M. et al. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet 386, 857\u2013866 (2015).","journal-title":"Lancet"},{"key":"5276_CR42","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.4049\/jimmunol.1602180","volume":"198","author":"D Betancourt","year":"2017","unstructured":"Betancourt, D., de Queiroz, N. M., Xia, T., Ahn, J. & Barber, G. N. Cutting edge: innate immune augmenting vesicular stomatitis virus expressing Zika virus proteins confers protective immunity. J. Immunol. 198, 3023\u20133028 (2017).","journal-title":"J. Immunol."},{"key":"5276_CR43","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.chom.2008.08.004","volume":"4","author":"TC Pierson","year":"2008","unstructured":"Pierson, T. C., Fremont, D. H., Kuhn, R. J. & Diamond, M. S. Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development. Cell Host Microbe 4, 229\u2013238 (2008).","journal-title":"Cell Host Microbe"},{"key":"5276_CR44","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.virol.2006.08.052","volume":"358","author":"SM Costa","year":"2007","unstructured":"Costa, S. M. et al. DNA vaccines against dengue virus based on the ns1 gene: the influence of different signal sequences on the protein expression and its correlation to the immune response elicited in mice. Virology 358, 413\u2013423 (2007).","journal-title":"Virology"},{"key":"5276_CR45","doi-asserted-by":"publisher","first-page":"8493","DOI":"10.1073\/pnas.0509821103","volume":"103","author":"J Li","year":"2006","unstructured":"Li, J., Wang, J. T. & Whelan, S. P. A unique strategy for mRNA cap methylation used by vesicular stomatitis virus. Proc. Natl Acad. Sci. USA 103, 8493\u20138498 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"5276_CR46","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1128\/JVI.03420-13","volume":"88","author":"Y Ma","year":"2014","unstructured":"Ma, Y. et al. mRNA cap methylation influences pathogenesis of vesicular stomatitis virus in vivo. J. Virol. 88, 2913\u20132926 (2014).","journal-title":"J. Virol."},{"key":"5276_CR47","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.chom.2016.03.010","volume":"19","author":"HM Lazear","year":"2016","unstructured":"Lazear, H. M. et al. A mouse model of Zika virus pathogenesis. Cell Host Microbe 19, 720\u2013730 (2016).","journal-title":"Cell Host Microbe"},{"key":"5276_CR48","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.4269\/ajtmh.16-0111","volume":"94","author":"SL Rossi","year":"2016","unstructured":"Rossi, S. L. et al. Characterization of a novel murine model to study Zika virus. Am. J. Trop. Med. Hyg. 94, 1362\u20131369 (2016).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"5276_CR49","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1128\/jvi.69.4.2153-2158.1995","volume":"69","author":"U Steinhoff","year":"1995","unstructured":"Steinhoff, U. et al. Antiviral protection by vesicular stomatitis virus-specific antibodies in alpha\/beta interferon receptor-deficient mice. J. Virol. 69, 2153\u20132158 (1995).","journal-title":"J. Virol."},{"key":"5276_CR50","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1600-065X.1995.tb00090.x","volume":"148","author":"MF van den Broek","year":"1995","unstructured":"van den Broek, M. F., Muller, U., Huang, S., Zinkernagel, R. M. & Aguet, M. Immune defence in mice lacking type I and\/or type II interferon receptors. Immunol. Rev. 148, 5\u201318 (1995).","journal-title":"Immunol. Rev."},{"key":"5276_CR51","first-page":"61","volume":"283","author":"SP Whelan","year":"2004","unstructured":"Whelan, S. P., Barr, J. N. & Wertz, G. W. Transcription and replication of nonsegmented negative-strand RNA viruses. Curr. Top. Microbiol. Immunol. 283, 61\u2013119 (2004).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"5276_CR52","doi-asserted-by":"publisher","first-page":"S1075","DOI":"10.1093\/infdis\/jir349","volume":"204","author":"TW Geisbert","year":"2011","unstructured":"Geisbert, T. W. & Feldmann, H. Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections. J. Infect. Dis. 204, S1075\u2013S1081 (2011).","journal-title":"J. Infect. Dis."},{"key":"5276_CR53","doi-asserted-by":"publisher","first-page":"e0003736","DOI":"10.1371\/journal.pntd.0003736","volume":"9","author":"D Safronetz","year":"2015","unstructured":"Safronetz, D. et al. A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses. PLoS Negl. Trop. Dis. 9, e0003736 (2015).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"5276_CR54","doi-asserted-by":"publisher","first-page":"5458","DOI":"10.1128\/JVI.78.10.5458-5465.2004","volume":"78","author":"M Garbutt","year":"2004","unstructured":"Garbutt, M. et al. Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses. J. Virol. 78, 5458\u20135465 (2004).","journal-title":"J. Virol."},{"key":"5276_CR55","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1128\/JVI.02308-14","volume":"89","author":"D Kurup","year":"2015","unstructured":"Kurup, D., Wirblich, C., Feldmann, H., Marzi, A. & Schnell, M. J. Rhabdovirus-based vaccine platforms against henipaviruses. J. Virol. 89, 144\u2013154 (2015).","journal-title":"J. Virol."},{"key":"5276_CR56","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1128\/JVI.01852-10","volume":"85","author":"A Chattopadhyay","year":"2011","unstructured":"Chattopadhyay, A. & Rose, J. K. Complementing defective viruses that express separate paramyxovirus glycoproteins provide a new vaccine vector approach. J. Virol. 85, 2004\u20132011 (2011).","journal-title":"J. Virol."},{"key":"5276_CR57","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.virol.2005.06.016","volume":"340","author":"SU Kapadia","year":"2005","unstructured":"Kapadia, S. U. et al. Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine. Virology 340, 174\u2013182 (2005).","journal-title":"Virology"},{"key":"5276_CR58","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ijid.2016.04.008","volume":"47","author":"S Perlman","year":"2016","unstructured":"Perlman, S. & Vijay, R. Middle East respiratory syndrome vaccines. Int. J. Infect. Dis. 47, 23\u201328 (2016).","journal-title":"Int. J. Infect. Dis."},{"key":"5276_CR59","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1128\/JVI.72.1.191-200.1998","volume":"72","author":"YL Lin","year":"1998","unstructured":"Lin, Y. L. et al. DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice. J. Virol. 72, 191\u2013200 (1998).","journal-title":"J. Virol."},{"key":"5276_CR60","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1099\/0022-1317-68-3-853","volume":"68","author":"JJ Schlesinger","year":"1987","unstructured":"Schlesinger, J. J., Brandriss, M. W. & Walsh, E. E. Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1. J. Gen. Virol. 68, 853\u2013857 (1987).","journal-title":"J. Gen. Virol."},{"key":"5276_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15039-8","volume":"7","author":"AC Brault","year":"2017","unstructured":"Brault, A. C. et al. A Zika vaccine targeting NS1 protein protects immunocompetent adult mice in a lethal challenge model. Sci. Rep. 7, 14769 (2017).","journal-title":"Sci. Rep."},{"key":"5276_CR62","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1126\/science.1185181","volume":"328","author":"W Dejnirattisai","year":"2010","unstructured":"Dejnirattisai, W. et al. Cross-reacting antibodies enhance dengue virus infection in humans. Science 328, 745\u2013748 (2010).","journal-title":"Science"},{"key":"5276_CR63","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.aaf8505","volume":"353","author":"K Stettler","year":"2016","unstructured":"Stettler, K. et al. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science 353, 823\u2013826 (2016).","journal-title":"Science"},{"key":"5276_CR64","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1126\/science.aal4365","volume":"356","author":"SV Bardina","year":"2017","unstructured":"Bardina, S. V. et al. Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity. Science 356, 175\u2013180 (2017).","journal-title":"Science"},{"key":"5276_CR65","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.immuni.2017.04.023","volume":"46","author":"JJ Miner","year":"2017","unstructured":"Miner, J. J. & Diamond, M. S. Dengue antibodies, then Zika: a fatal sequence in mice. Immunity 46, 771\u2013773 (2017).","journal-title":"Immunity"},{"key":"5276_CR66","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/ni.3515","volume":"17","author":"W Dejnirattisai","year":"2016","unstructured":"Dejnirattisai, W. et al. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus. Nat. Immunol. 17, 1102\u20131108 (2016).","journal-title":"Nat. Immunol."},{"key":"5276_CR67","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1093\/infdis\/jiw377","volume":"214","author":"AB Kawiecki","year":"2016","unstructured":"Kawiecki, A. B. & Christofferson, R. C. Zika virus-induced antibody response enhances dengue virus serotype 2 replication in vitro. J. Infect. Dis. 214, 1357\u20131360 (2016).","journal-title":"J. Infect. Dis."},{"key":"5276_CR68","doi-asserted-by":"publisher","first-page":"e1006184","DOI":"10.1371\/journal.ppat.1006184","volume":"13","author":"RD Pardy","year":"2017","unstructured":"Pardy, R. D. et al. Analysis of the T cell response to Zika virus and identification of a novel CD8+ T cell epitope in immunocompetent mice. PLoS Pathog. 13, e1006184 (2017).","journal-title":"PLoS Pathog."},{"key":"5276_CR69","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.chom.2016.12.010","volume":"21","author":"A Elong Ngono","year":"2017","unstructured":"Elong Ngono, A. et al. Mapping and role of the CD8+ T cell response during primary Zika virus infection in mice. Cell Host Microbe 21, 35\u201346 (2017).","journal-title":"Cell Host Microbe"},{"key":"5276_CR70","doi-asserted-by":"publisher","first-page":"13373","DOI":"10.1128\/JVI.79.21.13373-13384.2005","volume":"79","author":"J Li","year":"2005","unstructured":"Li, J., Fontaine-Rodriguez, E. C. & Whelan, S. P. Amino acid residues within conserved domain VI of the vesicular stomatitis virus large polymerase protein essential for mRNA cap methyltransferase activity. J. Virol. 79, 13373\u201313384 (2005).","journal-title":"J. Virol."},{"key":"5276_CR71","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.chom.2016.05.004","volume":"19","author":"C Shan","year":"2016","unstructured":"Shan, C. et al. An infectious cDNA clone of Zika virus to study viral virulence, mosquito transmission, and antiviral inhibitors. Cell Host Microbe 19, 891\u2013900 (2016).","journal-title":"Cell Host Microbe"},{"key":"5276_CR72","doi-asserted-by":"publisher","first-page":"8388","DOI":"10.1073\/pnas.92.18.8388","volume":"92","author":"SP Whelan","year":"1995","unstructured":"Whelan, S. P., Ball, L. A., Barr, J. N. & Wertz, G. T. Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones. Proc. Natl Acad. Sci. USA 92, 8388\u20138392 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-05276-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-05276-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-05276-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T16:19:33Z","timestamp":1671553173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-05276-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,3]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["5276"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-05276-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,3]]},"assertion":[{"value":"2 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3067"}}